Gene · 57794
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond canonical PROTAC: biological targeted protein degradation (bioTPD). | Biomater Res | 2023 | 37480049 | PubTator, text mining | PubMed |
| PUM1 Promotes Tumor Progression by Activating DEPTOR-Meditated Glycolysis in Gastric Cancer. | Adv Sci (Weinh) | 2023 | 37469018 | PubTator, text mining | PubMed |
| Landscape of semi-extractable RNAs across five human cell lines. | Nucleic Acids Res | 2023 | 37463833 | PubTator, text mining | PubMed |
| SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation. | J Clin Invest | 2023 | 37463047 | PubTator, text mining | PubMed |
| Transcriptomes of human primary skin fibroblasts of healthy individuals reveal age-associated mRNAs and long noncoding RNAs. | Aging Cell | 2023 | 37462262 | PubTator, text mining | PubMed |
| DPPA5A suppresses the mutagenic TLS and MMEJ pathways by modulating the cryptic splicing of Rev1 and Polq in mouse embryonic stem cells. | Proc Natl Acad Sci U S A | 2023 | 37459543 | PubTator, text mining | PubMed |
| Role of exosomes in the development of the immune microenvironment in hepatocellular carcinoma. | Front Immunol | 2023 | 37457718 | PubTator, text mining | PubMed |
| RNA-binding proteins that are highly expressed and enriched in healthy cartilage but suppressed in osteoarthritis. | Front Cell Dev Biol | 2023 | 37457300 | PubTator, text mining | PubMed |
| On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics. | Neural Regen Res | 2023 | 37449627 | PubTator, text mining | PubMed |
| Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review). | Oncol Rep | 2023 | 37449515 | PubTator, text mining | PubMed |
| Reviewing PTBP1 Domain Modularity in the Pre-Genomic Era: A Foundation to Guide the Next Generation of Exploring PTBP1 Structure-Function Relationships. | Int J Mol Sci | 2023 | 37446395 | PubTator, text mining | PubMed |
| TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells. | Cell Death Dis | 2023 | 37443145 | PubTator, text mining | PubMed |
| The identification of protein and RNA interactors of the splicing factor Caper in the adult Drosophila nervous system. | Front Mol Neurosci | 2023 | 37435576 | PubTator, text mining | PubMed |
| The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4. | Breast Cancer Res Treat | 2023 | 37433992 | PubTator, text mining | PubMed |
| YWHAH, a member of 14-3-3 family proteins, and PSME2, the proteasome activator subunit 2, are key host factors of Japanese encephalitis virus infection. | BMC Med Genomics | 2023 | 37430323 | PubTator, text mining | PubMed |
| Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC. | Genes Immun | 2023 | 37430022 | PubTator, text mining | PubMed |
| Two RNA binding proteins, ADAD2 and RNF17, interact to form a heterogeneous population of novel meiotic germ cell granules with developmentally dependent organelle association. | PLoS Genet | 2023 | 37428816 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cell therapy for the treatment of systemic rheumatic diseases: a comprehensive review of recent literature. | Ann Med Surg (Lond) | 2023 | 37427200 | PubTator, text mining | PubMed |
| Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy. | Anal Cell Pathol (Amst) | 2023 | 37426488 | PubTator, text mining | PubMed |
| Sequence- and structure-specific RNA oligonucleotide binding attenuates heterogeneous nuclear ribonucleoprotein A1 dysfunction. | Front Mol Biosci | 2023 | 37426420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57794/papers?page=30